AMH Equity’s Health Catalyst HCAT Stock Holding History
Bought
Maintained
Sold
Other funds holding HCAT
FLAM
WCA
NI
AMH Equity's HCAT Position: Q3 2025 in Review
AMH Equity increased its Health Catalyst (HCAT) stake by 55% in Q3 2025, buying an estimated $797K and bringing the position to 660,000 shares worth $1.88M. The position accounts for 2.34% of the portfolio, ranked #11.
AMH Equity first reported a position in HCAT in Q1 2025 and has held it in 3 quarters since. 145 funds tracked by Wall St. Rank hold HCAT as of Q3 2025.
- AMH Equity held 660,000 shares of Health Catalyst worth $1.88M as of Q3 2025.
- AMH Equity bought 232,851 Health Catalyst shares in Q3 2025, an estimated $797K.
- Health Catalyst made up 2.34% of AMH Equity's portfolio in Q3 2025, its #11 holding.
- AMH Equity first reported a position in Health Catalyst in Q1 2025 and has held it in 3 quarters since.
- 145 funds tracked by Wall St. Rank held Health Catalyst as of Q3 2025.
Based on AMH Equity's 13F filing for Q3 2025, filed 29 Oct 2025.